No Data
PEIJIA-B (09996.HK) plans to hold a Board of Directors meeting on March 25 to approve the annual performance.
Gelonghui, March 13 ─ PEIJIA-B (09996.HK) announced that the Board of Directors meeting will be held on March 25, 2025 (Tuesday) to consider and approve the annual performance of the company and its subsidiaries for the year ending December 31, 2024, and its release, as well as to consider the proposal for the payment of a final dividend (if any).
PEIJIA-B: DATE OF BOARD MEETING
After Leaping 31% Peijia Medical Limited (HKG:9996) Shares Are Not Flying Under The Radar
The new drug development time is cut in half, diagnoses are more accurate, industry barriers are lowered... AI is transforming the Medical Industry in China.
On February 26, Deutsche Bank Analyst Cyrus Ng released a report stating that the entire Medical Industry in China, from drug development and diagnostics to Hospital management, will benefit from the AI revolution.
The wave of AI in Medical is sweeping: the potential of the macromolecule new drug market is highlighted and imaging products are "going overseas" into Emerging Markets | Focus
① Some executives from pharmaceutical companies have stated that "currently, the discovery of small molecule drugs is very challenging; finding potential molecules and structures is already quite difficult, while there is still significant potential in the discovery and design of large molecule new drugs." ② Currently, the application maturity of AI technology in the imaging field is relatively high, and relevant manufacturers have revealed that the market potential for AI imaging large models in Belt and Road Initiative Concept countries is quite extensive.
Trending Industry Today: CARSGEN-B Leads Gains In Pharmaceutical Companies Stocks
Peijia Medical Limited's (HKG:9996) 29% Share Price Plunge Could Signal Some Risk
